Driving speed, simplicity and scale in drug development

At CPHI, Olivia Friett, editor of European Pharmaceutical Manufacturer spoke to Anil Kane, head of global technical & scientific affairs at Thermo Fisher Scientific, about what they were showcasing.

In an industry defined by complexity, shifting regulations and increasing pressure to deliver therapies faster, the companies that make the biggest impact are often the ones able to simplify the journey. At this year’s CPHI, Thermo Fisher Scientific outlined how it is doing exactly that – bringing together infrastructure, expertise and now advanced AI to help biopharma partners…